Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Clinical Progress Update From PRO-101, a Hybrid Phase One Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Prosetin in Participants With ALS

Phencyclidine Causing Opsoclonus and Myoclonus in a Four-month-old